The Adherence to Oral Second Line Antidiabetic Medication in People with Type 2 Diabetes - A Protocol for a Systematic Review

Authors

  • Nynne Sophie Holdt-Caspersen
  • Stine Hangaard Casper
  • Peter Vestergaard
  • Claus Dethlefsen
  • Morten Hasselstrøm Jensen

DOI:

https://doi.org/10.3384/ecp187035

Keywords:

Type 2 diabetes, Adherence, Oral antidiabetics, Systematic review, Protocol

Abstract

The treatment goal in type 2 diabetes (T2D) is to keep the blood glucose within a target range. In the early stages of diabetes, the treatment may consist entirely of oral antidiabetics (OAD), which may be preferable over injectables for some people. However, previously published systematic reviews found a low OAD adherence and that the adherence differs between different OAD types. These systematic reviews were performed before 2015, and several new OADs have been marketed since then. Thus, a systematic review will be undertaken to review the newest studies on adherence to oral second line antidiabetics in people with T2D.

Downloads

Published

2022-08-22

Issue

Proceedings of the 18th Scandinavian Conference on Health Informatics

Section

Contents

License

Copyright (c) 2022 Nynne Sophie Holdt-Caspersen, Stine Hangaard Casper, Peter Vestergaard, Claus Dethlefsen, Morten Hasselstrøm Jensen

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.